Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Fåhraeus Startup & Growth is a venture capital fund based in Lund, Sweden, founded in 2021. The firm evolved from the Fårö Capital family office, which has been active since 2000. Fåhraeus Startup & Growth aims to support early-stage startups that are developing innovative solutions in the life sciences and technology sectors. The fund has a strong emphasis on diagnostics and pharmaceuticals, leveraging a team with over 250 years of combined board experience across Nordic tech and life science companies.
Currently, Fåhraeus Startup & Growth manages a fund size of approximately $75 million, with a focus on pre-seed, seed, and seed-plus stages. The firm has made six investments since the launch of its second fund in mid-2023. The team is composed of five partners, each bringing a wealth of experience from various sectors, particularly in life sciences and technology. The firm is strategically located in Lund, which is part of the Medicon Valley, a prominent life science corridor in Europe.
Fåhraeus Startup & Growth focuses on investing in early-stage startups that are developing groundbreaking solutions in life sciences and technology. The firm emphasizes sectors such as biotech, healthcare, AI, fintech, energy, climate, consumer, SaaS, and commerce. The fund specifically targets companies that demonstrate commercial traction and innovative approaches to address significant challenges in diagnostics and pharmaceuticals.
The investment strategy includes a strong commitment to sustainability, which is a cross-cutting principle across all sectors. Fåhraeus Startup & Growth seeks to partner with founders who are not only innovative but also have a clear vision for their companies. The firm prefers to invest in startups that are at the pre-seed, seed, and seed-plus stages, allowing them to provide support from the earliest phases of development.
Fåhraeus Startup & Growth has a diverse portfolio that includes six notable companies:
Christer Fåhraeus — General Partner; a serial entrepreneur who founded Cellavision, EQL Pharma, and Anoto. He has a background in mathematics, medicine, and bioengineering.
Linus Wiebe — Managing General Partner; previously served as Director of Innovation at Lund University and has experience at Ericsson and ARM.
Johanna Asklin — General Partner; holds a PhD in Medicine and has 15 years of experience in life sciences strategy, focusing on diagnostics and therapeutics.
Emanuel Stihl — Partner; serves as CEO of FSG Fund I and has a background in banking and investment management.
Alexander Jöndell — Partner; specializes in medtech and consumer tech, with a former background as CFO/COO.
To pitch to Fåhraeus Startup & Growth, founders should visit the firm's website at fsgfond.com or send an email to info@fsgfond.com. It is essential to include a comprehensive pitch deck that outlines the startup's business model, market opportunity, and team qualifications. The firm appreciates clear and concise presentations that highlight innovative solutions in life sciences and technology.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In mid-2023, Fåhraeus Startup & Growth launched its second fund, FSG Fund II, which has a size of SEK 848 million (approximately $75 million). The fund has already made six investments, including notable companies such as Saga Dx, Promimic, and OssDsign. The European Investment Fund (EIF) committed SEK 233 million as an anchor LP, signaling strong institutional confidence in the fund.
Fåhraeus Startup & Growth continues to focus on early-stage investments in the Nordic region, particularly in life sciences and technology sectors. The firm is actively seeking innovative startups that align with its investment thesis.
What are Fåhraeus Startup & Growth's investment criteria?
Fåhraeus Startup & Growth invests in early-stage startups primarily in the life sciences and technology sectors. The firm looks for companies that demonstrate commercial traction and innovative solutions, particularly in diagnostics and pharmaceuticals.
How can I apply or pitch to Fåhraeus Startup & Growth?
Founders can pitch their startups by visiting the firm's website at fsgfond.com or by emailing info@fsgfond.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Fåhraeus Startup & Growth different from other VC firms?
The firm has a unique focus on the Nordic region and specializes in life sciences and technology, particularly diagnostics and pharmaceuticals. The team has over 250 years of combined experience, providing significant value through strategic guidance and industry connections.
What is the geographic scope of Fåhraeus Startup & Growth?
Fåhraeus Startup & Growth primarily focuses on investments within Europe, particularly in the Nordic region, leveraging its location in Lund, Sweden, which is part of the Medicon Valley.
What is the fund size and check size range?
The current fund size is approximately $75 million. The firm typically invests in early-stage rounds, with check sizes varying based on the specific needs of the startup.
What kind of post-investment involvement can startups expect?
Fåhraeus Startup & Growth provides significant support to its portfolio companies, including access to a vast network of industry contacts, strategic guidance, and assistance in navigating the complexities of the life science and technology sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.